vs
Side-by-side financial comparison of CROSS COUNTRY HEALTHCARE INC (CCRN) and ESCO TECHNOLOGIES INC (ESE). Click either name above to swap in a different company.
ESCO TECHNOLOGIES INC is the larger business by last-quarter revenue ($289.7M vs $236.8M, roughly 1.2× CROSS COUNTRY HEALTHCARE INC). ESCO TECHNOLOGIES INC runs the higher net margin — 9.9% vs -35.0%, a 44.9% gap on every dollar of revenue. On growth, ESCO TECHNOLOGIES INC posted the faster year-over-year revenue change (17.3% vs -23.6%). ESCO TECHNOLOGIES INC produced more free cash flow last quarter ($63.0M vs $16.1M). Over the past eight quarters, ESCO TECHNOLOGIES INC's revenue compounded faster (7.8% CAGR vs -21.0%).
GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...
Esco is a Singaporean brand that develops, manufactures, and sells products and services for laboratories.
CCRN vs ESE — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $236.8M | $289.7M |
| Net Profit | $-82.9M | $28.7M |
| Gross Margin | — | 41.4% |
| Operating Margin | -30.2% | 13.2% |
| Net Margin | -35.0% | 9.9% |
| Revenue YoY | -23.6% | 17.3% |
| Net Profit YoY | -2109.7% | 22.2% |
| EPS (diluted) | $-2.56 | $1.11 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $236.8M | $289.7M | ||
| Q3 25 | $250.1M | $286.5M | ||
| Q2 25 | $274.1M | $296.3M | ||
| Q1 25 | $293.4M | $265.5M | ||
| Q4 24 | $309.9M | $247.0M | ||
| Q3 24 | $315.1M | $298.5M | ||
| Q2 24 | $339.8M | $260.8M | ||
| Q1 24 | $379.2M | $249.1M |
| Q4 25 | $-82.9M | $28.7M | ||
| Q3 25 | $-4.8M | $218.7M | ||
| Q2 25 | $-6.7M | $26.1M | ||
| Q1 25 | $-490.0K | $31.0M | ||
| Q4 24 | $-3.8M | $23.5M | ||
| Q3 24 | $2.6M | $34.3M | ||
| Q2 24 | $-16.1M | $29.2M | ||
| Q1 24 | $2.7M | $23.2M |
| Q4 25 | — | 41.4% | ||
| Q3 25 | 20.4% | 45.9% | ||
| Q2 25 | 20.4% | 41.2% | ||
| Q1 25 | 20.0% | 41.1% | ||
| Q4 24 | — | 39.8% | ||
| Q3 24 | 20.4% | 40.1% | ||
| Q2 24 | 20.8% | 39.6% | ||
| Q1 24 | 20.4% | 38.8% |
| Q4 25 | -30.2% | 13.2% | ||
| Q3 25 | -2.4% | 17.2% | ||
| Q2 25 | -2.1% | 11.2% | ||
| Q1 25 | -0.3% | 15.3% | ||
| Q4 24 | -1.1% | 11.4% | ||
| Q3 24 | 0.9% | 14.8% | ||
| Q2 24 | -5.7% | 14.3% | ||
| Q1 24 | 0.8% | 11.7% |
| Q4 25 | -35.0% | 9.9% | ||
| Q3 25 | -1.9% | 76.3% | ||
| Q2 25 | -2.4% | 8.8% | ||
| Q1 25 | -0.2% | 11.7% | ||
| Q4 24 | -1.2% | 9.5% | ||
| Q3 24 | 0.8% | 11.5% | ||
| Q2 24 | -4.7% | 11.2% | ||
| Q1 24 | 0.7% | 9.3% |
| Q4 25 | $-2.56 | $1.11 | ||
| Q3 25 | $-0.15 | $8.43 | ||
| Q2 25 | $-0.20 | $1.01 | ||
| Q1 25 | $-0.02 | $1.20 | ||
| Q4 24 | $-0.13 | $0.91 | ||
| Q3 24 | $0.08 | $1.32 | ||
| Q2 24 | $-0.47 | $1.13 | ||
| Q1 24 | $0.08 | $0.90 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $108.7M | $103.8M |
| Total DebtLower is stronger | — | $145.5M |
| Stockholders' EquityBook value | $322.8M | $1.6B |
| Total Assets | $449.0M | $2.4B |
| Debt / EquityLower = less leverage | — | 0.09× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $108.7M | $103.8M | ||
| Q3 25 | $99.1M | $101.3M | ||
| Q2 25 | $81.2M | $78.7M | ||
| Q1 25 | $80.7M | $57.4M | ||
| Q4 24 | $81.6M | $71.3M | ||
| Q3 24 | $64.0M | $66.0M | ||
| Q2 24 | $69.6M | $63.0M | ||
| Q1 24 | $5.2M | $59.4M |
| Q4 25 | — | $145.5M | ||
| Q3 25 | — | $186.0M | ||
| Q2 25 | — | $525.0M | ||
| Q1 25 | — | $88.0M | ||
| Q4 24 | — | $112.0M | ||
| Q3 24 | — | $122.0M | ||
| Q2 24 | — | $173.0M | ||
| Q1 24 | — | $191.0M |
| Q4 25 | $322.8M | $1.6B | ||
| Q3 25 | $408.1M | $1.5B | ||
| Q2 25 | $412.2M | $1.3B | ||
| Q1 25 | $418.2M | $1.3B | ||
| Q4 24 | $419.0M | $1.2B | ||
| Q3 24 | $424.7M | $1.2B | ||
| Q2 24 | $433.3M | $1.2B | ||
| Q1 24 | $462.4M | $1.2B |
| Q4 25 | $449.0M | $2.4B | ||
| Q3 25 | $538.2M | $2.4B | ||
| Q2 25 | $553.8M | $2.5B | ||
| Q1 25 | $576.2M | $1.8B | ||
| Q4 24 | $589.3M | $1.8B | ||
| Q3 24 | $597.4M | $1.8B | ||
| Q2 24 | $602.9M | $1.8B | ||
| Q1 24 | $648.4M | $1.8B |
| Q4 25 | — | 0.09× | ||
| Q3 25 | — | 0.12× | ||
| Q2 25 | — | 0.40× | ||
| Q1 25 | — | 0.07× | ||
| Q4 24 | — | 0.09× | ||
| Q3 24 | — | 0.10× | ||
| Q2 24 | — | 0.14× | ||
| Q1 24 | — | 0.16× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $18.2M | $68.9M |
| Free Cash FlowOCF − Capex | $16.1M | $63.0M |
| FCF MarginFCF / Revenue | 6.8% | 21.7% |
| Capex IntensityCapex / Revenue | 0.9% | 2.0% |
| Cash ConversionOCF / Net Profit | — | 2.40× |
| TTM Free Cash FlowTrailing 4 quarters | $40.1M | $239.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $18.2M | $68.9M | ||
| Q3 25 | $20.1M | $109.9M | ||
| Q2 25 | $4.2M | $73.7M | ||
| Q1 25 | $5.7M | $24.1M | ||
| Q4 24 | $24.2M | $34.2M | ||
| Q3 24 | $7.5M | $72.1M | ||
| Q2 24 | $82.4M | $36.2M | ||
| Q1 24 | $6.0M | $10.5M |
| Q4 25 | $16.1M | $63.0M | ||
| Q3 25 | $17.9M | $97.8M | ||
| Q2 25 | $2.3M | $64.9M | ||
| Q1 25 | $3.8M | $14.0M | ||
| Q4 24 | $21.7M | $29.0M | ||
| Q3 24 | $6.3M | $60.9M | ||
| Q2 24 | $79.6M | $27.6M | ||
| Q1 24 | $3.8M | $2.0M |
| Q4 25 | 6.8% | 21.7% | ||
| Q3 25 | 7.2% | 34.1% | ||
| Q2 25 | 0.8% | 21.9% | ||
| Q1 25 | 1.3% | 5.3% | ||
| Q4 24 | 7.0% | 11.7% | ||
| Q3 24 | 2.0% | 20.4% | ||
| Q2 24 | 23.4% | 10.6% | ||
| Q1 24 | 1.0% | 0.8% |
| Q4 25 | 0.9% | 2.0% | ||
| Q3 25 | 0.9% | 4.2% | ||
| Q2 25 | 0.7% | 3.0% | ||
| Q1 25 | 0.6% | 3.8% | ||
| Q4 24 | 0.8% | 2.1% | ||
| Q3 24 | 0.4% | 3.8% | ||
| Q2 24 | 0.8% | 3.3% | ||
| Q1 24 | 0.6% | 3.4% |
| Q4 25 | — | 2.40× | ||
| Q3 25 | — | 0.50× | ||
| Q2 25 | — | 2.83× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 1.46× | ||
| Q3 24 | 2.92× | 2.10× | ||
| Q2 24 | — | 1.24× | ||
| Q1 24 | 2.23× | 0.45× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CCRN
| Temporary Staffing Services | $189.6M | 80% |
| Physician Staffing | $42.5M | 18% |
| Other Services | $4.7M | 2% |
ESE
| US Government | $98.0M | 34% |
| Utility Solutions Group | $87.5M | 30% |
| RF Shielding And Test | $58.3M | 20% |
| Commercial | $45.8M | 16% |
| Related Party | $1.3M | 0% |
